Your browser doesn't support javascript.
loading
ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma.
Zhang, Yao-Hua; Zeng, Jing; Liu, Xu-Sheng; Gao, Yan; Kui, Xue-Yan; Liu, Xiao-Yu; Zhang, Yu; Pei, Zhi-Jun.
Affiliation
  • Zhang YH; Department of Nuclear Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
  • Zeng J; Department of Infection Control, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
  • Liu XS; Department of Nuclear Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
  • Gao Y; Department of Nuclear Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
  • Kui XY; Department of Nuclear Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
  • Liu XY; Department of Nuclear Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
  • Zhang Y; Department of Nuclear Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
  • Pei ZJ; Department of Nuclear Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Front Endocrinol (Lausanne) ; 13: 1013238, 2022.
Article in En | MEDLINE | ID: mdl-36299451
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma of Lung / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Front Endocrinol (Lausanne) Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma of Lung / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Front Endocrinol (Lausanne) Year: 2022 Document type: Article Affiliation country: Country of publication: